Drug profile · INN
selegiline hydrochloride
ZELAPAR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
selegiline hydrochloride (ZELAPAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN selegiline hydrochloride
Brand ZELAPAR
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING
Frequently asked questions
What is selegiline hydrochloride?
selegiline hydrochloride (ZELAPAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for selegiline hydrochloride?
ZELAPAR is a marketed brand name for selegiline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of selegiline hydrochloride?
selegiline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.